Skip to main content
logo
Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.5499
-0.0001 (-0.02%)
Jul 23, 2025, 3:59 PM EDT

Elite Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Elite Pharmaceuticals had annual revenue of $84.04M with 48.42% growth. Elite Pharmaceuticals had revenue of $32.00M in the quarter ending March 31, 2025, with 78.26% growth.

Revenue
84.04M
Revenue Growth
+48.42%
P/S Ratio
7.01
Revenue / Employee
1.24M
Employees
68
Market Cap
588.81M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202584.04M27.42M48.42%
Mar 31, 202456.63M22.47M65.79%
Mar 31, 202334.16M1.89M5.87%
Mar 31, 202232.26M6.88M27.11%
Mar 31, 202125.38M7.39M41.05%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Endo, Inc.1.73B
Veradigm588.02M
Tian'an Technology Group1.78M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
Silence Therapeutics27.70M
BioStem Technologies332.45M
Revenue Rankings

Elite Pharmaceuticals News

More News